维普中文期刊产品整合服务
103篇 您的检索式:作者名="Zhu LS"
    题名 作者 年代 出处 被引量
1急性心肌缺血综合征中国地区现状调查显示文摘目的研究分析中国地区急性心肌缺血综合征病人的临床特点和治疗现状.方法此项研究为国际多中心关于急性心肌缺血综合征登记试验(OASIS)的一部分.采用填写加拿大心血管合作协会统一设计的病例记录表(CRF)的方法,自1999年4月开始,收集了各中心因急性心肌缺血入院病人的资料,记录了病人主要临床特征和院内事件.结果共注册急性心肌缺血综合征(包括不稳定心绞痛及非Q波心肌梗死)病人1509例,来自全国范围内34所医院.病人平均年龄62.3岁,其中男性62.2%,就诊时持续胸痛47.8%,心电图异常89.5%,入院诊断不稳定心绞痛91.3%,非Q波心肌梗死8.7%.住院期间溶栓3.3%,冠状动脉造影35.0%,经皮冠状动脉腔内成形术(PTCA)16.8%,冠状动脉旁路移植术(CABG)4.1%,应用硝酸酯制剂96.8%,抗血小板治疗95.5%.院内发生重要并发症18.8%,其中死亡1.2%,主要原因为严重心律失常或猝死.结论中国地区急性心肌缺血病人以不稳定心绞痛就诊居多.我国病人住院期间PTCA治疗率相对较高,CABG治疗率较低.院内死亡最主要的原因为严重心律失常或猝死. Tan HQ Liang Y Zhu J Liu LS Cronin L 2002Chinese Medical Journal2002,,8:3
2St John's wort induces both cytochrome P450 3A4 -catalyzed sulfoxidation and 2C19 -dependent hydroxylation of omeprazole显示文摘Wang LS Zhou G Zhu B 2004Clin Pharmacol Ther2004,75,:1
3Specific aptamer-protein interaction studied by atomic force microscopy显示文摘Jiang YX Zhu CF Ling LS 2003Anal Chem2003,75,9:1
4Phase 2 study of cetuximah in patients with advanced hepatocellular carcinoma 显示文摘Zhu AX Stuart K Blaszkowsky LS etal 2007Cancer2007,110,3:1
5The influence of St John's wort on CYP2C19 activity with respect to genotype显示文摘Wang LS Zhu B El -Aty AM 2004J Clin Pharmacol2004,44,:1
6Rhein reverses the diabetic phenotype of mesangial cells over-expressing the glucose transporter(GLUT1)by inhibiting the hexosamine pathway显示文摘Zheng JM Zhu JM Li LS 2008Br J Pharmacol2008,153,7:1
7Molecular cloning,characterization and expression of a novel serine proteinase inhibitor gene in bay scallops(Argopecten irrodians,Lamarck 1819)显示文摘ZHU L SONG LS CHANG YQ 2006Fish Shellfish Immunol2006,20,3:1
8Is combination rituximab with cyclophosphamide better than rituximab alone in the treatment of lupus nephritis 显示文摘Li EK Tam LS Zhu TY 2009Rheumatology (Oxford)2009,48,8:1
9Molecular cloning,characterization and expression of a serine protease with clipdomain homologue from scallop Chlamys,farreri显示文摘ZHU L SONG LS ZHAO JM 2007Fish Shellfish Immunol2007,22,5:1
10Calmodulin regulation of excitation-contraction coupling in cardiac myocytes显示文摘Yang D Song LS Zhu WZ 2003Circ Res2003,92,6:1
11Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced bili- ary-tract cancers and correlation of changes in 18-fluorodeoxyglu- cose PET with clinical outcome: a phase 2 study显示文摘Zhu AX Meyerhardt JA Blaszkowsky LS 2010Lancet Oncol2010,11,1:1
12Cortical expression of endothelin receptor subtypes A and B following middle cerebral artery occlusion in rats显示文摘Loo LS Ng YK Zhu YZ 2002Neuroscience2002,112,4:1
13Calmodulin regulation of excitation-contraction coupling in cardiac myocytes显示文摘YANG D SONG LS ZHU WZ 2003Circ Res2003,92,:1
14Efficacy and safety of gemcitabine,oxaliplatin,and bevacizumab in advanced biliarytract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome:a phase 2 study显示文摘Zhu AX Meyerhardt JA Blaszkowsky LS 2010Lancet Oncol2010,11,1:1
15Phase II study of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinoma 显示文摘Zhu AX Blaszkowsky LS Ryan DP 2006J Clin Oncol2006,24,:1
16PTEN ameliorates high glucose-induced lipid deposits regulating SREBP-1/FASN/ACC pathway in renal proximal tubular cells显示文摘Hao J Zhu LS Liu Q 2011Exp Cell Res2011,317,11:1
17Efficacy and safety of gemcitabine,oxaliplatin,and bevaeizumab in advanced biliarytract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome:a phase 2 study显示文摘Zhu AX Meyerhardt JA Blaszkowsky LS 0,,01:1
18Phase 2 study Of cetuximab in patients with advanced hepatoceUular carcinoma 显示文摘Zhu AX Stuart K Blaszkowsky LS et a 2007Cancer2007,110,3:1
19Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary- tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study显示文摘Zhu AX MeyerhardtJA Blaszkowsky LS 2010Lancet Oncol2010,11,1:1
20Predictors of maternal and fetal outcomes in pregnancies of patients with systemic lupus erythe- matosus 显示文摘Kwok LW Tam LS Zhu T 2011Lupus2011,20,8:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费